TAXOTERE is a microtubule inhibitor indicated for: Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC Non-small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for ... WebFood and Drug Administration
TAXOTERE - PLM
WebTaxotere (R) is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Taxotere (R) in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. Non-Small Cell Lung Cancer (NSCLC) WebTAXOTERE i kombination med doxorubicin er indiceret til behandling af patienter med lokalt fremskreden eller metastatisk brystkræft, som ikke tidligere har fået kemoterapi mod denne tilstand. TAXOTERE monoterapi er indiceret til behandling af patienter med lokalt fremskreden eller metastatisk brystkræft efter behandlingssvigt af kemoterapi. sanborn north dakota
Taxotere European Medicines Agency
WebTaxotere - Chemotherapy Drugs - Chemocare Generic Name: Docetaxel Drug Type: Taxotere is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Taxotere is classified as a "plant alkaloid," a "taxane" and an "antimicrotubule agent." (For more detail, see "How Taxotere Works" section below). What Taxotere Is Used For: WebDec 22, 2024 · TAXOTERE is a cytotoxic anticancer drug and, as with other potentially toxic compounds, caution should be exercised when handling and preparing TAXOTERE solutions. The use of gloves is recommended [see … WebAug 7, 2024 · The group of patients treated with Taxotere received more cycles of chemotherapy than the group treated with Taxol. The researchers concluded that long-term results continue to indicate that Taxotere improves survival compared with Taxol in the treatment of patients with metastatic breast cancer who have received prior therapy with … sanborn oplin